The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance
- PMID: 16904340
- DOI: 10.1016/j.semcancer.2006.07.002
The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance
Abstract
Natural killer (NK) cells have important functions in the innate immunity to tumors. Recognition of tumor cells by NK cells is mediated by the interaction of activating and inhibitory NK cell receptors with ligands expressed on the tumor target. In addition, NK cell-target cell interactions require the engagement of adhesion molecules that stabilize the cell-cell conjugate. Recently, several novel NK cell receptors have been reported to regulate NK cell adhesion and activation through interaction with ligands of the nectin and nectin-like (Necl) family of adhesion molecules. We here review current knowledge on these receptors, CD226, CD96 and CRTAM, and their role in tumor immunosurveillance.
Similar articles
-
PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.Mol Immunol. 2005 Feb;42(4):463-9. doi: 10.1016/j.molimm.2004.07.028. Mol Immunol. 2005. PMID: 15607800
-
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.J Exp Med. 2003 Aug 18;198(4):557-67. doi: 10.1084/jem.20030788. Epub 2003 Aug 11. J Exp Med. 2003. PMID: 12913096 Free PMC article.
-
Heterotypic interaction of CRTAM with Necl2 induces cell adhesion on activated NK cells and CD8+ T cells.Int Immunol. 2005 Sep;17(9):1227-37. doi: 10.1093/intimm/dxh299. Epub 2005 Aug 9. Int Immunol. 2005. PMID: 16091383
-
[Nectins and nectin-like receptors DNAM-1 and CRTAM: new ways for tumor escape].Med Sci (Paris). 2014 May;30(5):537-43. doi: 10.1051/medsci/20143005017. Epub 2014 Jun 13. Med Sci (Paris). 2014. PMID: 24939541 Review. French.
-
Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancer.Curr Opin Immunol. 2012 Apr;24(2):246-51. doi: 10.1016/j.coi.2012.01.009. Epub 2012 Jan 28. Curr Opin Immunol. 2012. PMID: 22285893 Review.
Cited by
-
Immune checkpoint targeting TIGIT in hepatocellular carcinoma.Am J Transl Res. 2020 Jul 15;12(7):3212-3224. eCollection 2020. Am J Transl Res. 2020. PMID: 32774695 Free PMC article. Review.
-
Immune cellular components and signaling pathways in the tumor microenvironment.Semin Cancer Biol. 2022 Nov;86(Pt 2):187-201. doi: 10.1016/j.semcancer.2022.08.004. Epub 2022 Aug 18. Semin Cancer Biol. 2022. PMID: 35985559 Free PMC article. Review.
-
CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity.Oncoimmunology. 2018 Feb 1;7(5):e1424677. doi: 10.1080/2162402X.2018.1424677. eCollection 2018. Oncoimmunology. 2018. PMID: 29721390 Free PMC article.
-
Therapeutic Antibodies for Myeloid Neoplasms-Current Developments and Future Directions.Front Oncol. 2018 May 18;8:152. doi: 10.3389/fonc.2018.00152. eCollection 2018. Front Oncol. 2018. PMID: 29868474 Free PMC article. Review.
-
DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy.Cancers (Basel). 2019 Jun 23;11(6):877. doi: 10.3390/cancers11060877. Cancers (Basel). 2019. PMID: 31234588 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases